Full Text View
Tabular View
No Study Results Posted
Related Studies
Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection
This study has been completed.
Study NCT00000790   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on November 2, 1999.   Last Updated on March 30, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Stomatitis, Aphthous
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Stomatitis
Viremia
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Inflammation
Lentivirus Infections
Mouth Diseases
Pathologic Processes
Retroviridae Infections
RNA Virus Infections
Sepsis
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Stomatognathic Diseases
Systemic Inflammatory Response Syndrome
Virus Diseases
Interventions listed in this trial
Thalidomide
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Bacterial Agents
Anti-Infective Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Leprostatic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Andrulis Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services